CNC Centene (CNC) Insider Trading, Ownership & Congress Trades
Insurance · Hospital & medical service plans · CIK 0001071739
Form 144 · 4
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
571
13F, latest reported quarter
What the filings say about CNC
Insiders, 180 days
-$12.1M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-08-18
Planned sales (Form 144), 90 days
$16.5M
4 notices
Centene insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CENTENE CORP insiders sold a net $12.1M of stock across 53 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Aug 18, 2026.
- The trade is 22.7% of the 248,853 shares held after it.
- No other insider sold within 30 days.
- 571 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Secretary & General Counsel KOSTER CHRISTOPHER sold about $3.8M of CNC on Aug 26, 2026; 571 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Oct 28, 2021.
- The trade is 15.6% of the 305,353 shares held after it.
- No other insider sold within 30 days.
- 571 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Secretary & General Counsel KOSTER CHRISTOPHER sold about $3.1M of CNC on Aug 18, 2026; 571 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Dec 4, 2025.
- The trade is 40.6% of the 197,085 shares held after it.
- No other insider sold within 30 days.
- 571 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Burdick Kenneth A sold about $5.2M of CNC on Jun 10, 2026, the largest insider sale at the company on our record; 571 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Dec 3, 2025.
- The trade is 12.0% of the 272,364 shares held after it.
- No other insider sold within 30 days.
- 571 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Burdick Kenneth A sold about $1.3M of CNC on Dec 4, 2025; 571 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 10.9% of the 305,160 shares held after it.
- No other insider sold within 30 days.
- 571 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Burdick Kenneth A sold about $1.3M of CNC on Dec 3, 2025, the largest insider sale at the company since 2021; 571 funds added in the latest 13F quarter.53 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$12.1M over 180 days
-$6.9M over 90 days
below 75% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
571 funds bought in last quarter
more than 88% of Insurance
Revenue
+20.0% year over year
more than 68% of Insurance
Margin
-3.8% net margin
below 87% of Insurance
Buybacks
$33.0M repurchased, FY to 2026-06-30
below 78% of Insurance
Short interest
2.3% of the float short (float per yahoo 2026-10-26) · 2.0 days to cover · settled 2026-09-30
below 68% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CNC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+98.0%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CNC: institutional holders (13F)
13F holdings, latest reported quarter
41,446,046 sh
$2.7B
31,478,140 sh
$2.0B
28,678,701 sh
$1.8B
22,352,704 sh
$1.4B
21,965,370 sh
$1.4B
Congress trades in CNC
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-08-18 · disclosed 16 days later
$100,001 - $250,000
Bought 2025-08-08 · disclosed 26 days later
$1,001 - $15,000
Sold 2025-08-08 · disclosed 158 days later
$1,001 - $15,000
Bought 2025-08-07 · disclosed 27 days later
$15,001 - $50,000
Bought 2025-08-05 · disclosed 38 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CNC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Burdick Kenneth A
Filed 2026-08-26
$2.8M
KOSTER CHRISTOPHER
Filed 2026-08-26
$3.8M
KOSTER CHRISTOPHER
Filed 2026-08-18
$3.1M
Burdick Kenneth A
Filed 2026-08-05
$6.8M
CNC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Oakmark Select Fund
$483.0M position · as of 2026-06-30
5.8%
iShares U.S. Healthcare Providers ETF
$49.7M position · as of 2026-06-30
4.2%
Scharf Global Opportunity ETF
$6.6M position · as of 2026-06-30
4.1%
Adaptiv Select ETF
$6.5M position · as of 2026-07-31
3.6%
Scharf ETF
$22.4M position · as of 2026-06-30
3.4%
First Trust Lunt U.S. Factor Rotation ETF
$1.8M position · as of 2026-06-30
3.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · London
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$19.5M
$4.6M
$7.7M
-31%
+48%
2024
$20.6M
$5.4M
$7.2M
+1%
+29%
2023
$18.6M
$14.0M
$7.6M
+24%
+26%
2021
$20.6M
$42.3M
$9.9M
+37%
+26%
2020
$25.0M
$25.0M
$8.6M
-5%
+13%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $12.1M sold by insiders over 180 days, 571 funds added last quarter, $16.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CNC financials
Revenue growth
+20.0%
XBRL, annual
Net margin
-3.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$202.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CNC
| FY Dec 2025 | $194.8B |
| FY Dec 2024 | $163.1B |
| FY Dec 2023 | $154.0B |
| FY Dec 2022 | $144.5B |
| FY Dec 2021 | $126.0B |
| Jun 2026 | $53.6B |
| Mar 2026 | $49.9B |
| Dec 2025 | $49.7B |
| Sep 2025 | $49.7B |
| Jun 2025 | $48.7B |
| Mar 2025 | $46.6B |
| Dec 2024 | $40.8B |
| Sep 2024 | $42.0B |
At each fiscal year end
Single quarter
Net margin, TTM
-2.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CNC
| FY Dec 2025 | -3.4% |
| FY Dec 2024 | +2.0% |
| FY Dec 2023 | +1.8% |
| FY Dec 2022 | +0.8% |
| FY Dec 2021 | +1.1% |
| Jun 2026 | +2.0% |
| Mar 2026 | +3.1% |
| Dec 2025 | -2.2% |
| Sep 2025 | -13.3% |
| Jun 2025 | -0.5% |
| Mar 2025 | +2.8% |
| Dec 2024 | +0.7% |
| Sep 2024 | +1.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$9.0B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CNC
| FY Dec 2025 | $4.3B |
| FY Dec 2024 | -$490.0M |
| FY Dec 2023 | $7.3B |
| FY Dec 2022 | $5.3B |
| FY Dec 2021 | $3.3B |
| Jun 2026 | $3.4B |
| Mar 2026 | $4.2B |
| Dec 2025 | $224.0M |
| Sep 2025 | $1.1B |
| Jun 2025 | $1.6B |
| Mar 2025 | $1.4B |
| Dec 2024 | -$741.0M |
| Sep 2024 | -$1.1B |
At each fiscal year end
Single quarter
Debt to equity
0.71x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CNC
| FY Dec 2025 | 0.87x |
| FY Dec 2024 | 0.70x |
| FY Dec 2023 | 0.69x |
| FY Dec 2022 | 0.75x |
| FY Dec 2021 | 0.70x |
| Jun 2026 | 0.71x |
| Mar 2026 | 0.76x |
| Dec 2025 | 0.87x |
| Sep 2025 | 0.84x |
| Jun 2025 | 0.64x |
| Mar 2025 | 0.66x |
| Dec 2024 | 0.70x |
| Sep 2024 | 0.64x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.61x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CNC
| FY Dec 2025 | 0.29x |
| FY Dec 2024 | 0.01x |
| FY Dec 2023 | 0.45x |
| FY Dec 2022 | 0.35x |
| FY Dec 2021 | 0.22x |
| Jun 2026 | 0.61x |
| Mar 2026 | 0.49x |
| Dec 2025 | 0.29x |
| Sep 2025 | 0.23x |
| Jun 2025 | 0.10x |
| Mar 2025 | 0.12x |
| Dec 2024 | 0.01x |
| Sep 2024 | 0.05x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-20.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CNC
| FY Dec 2025 | -28.8% |
| FY Dec 2024 | +12.7% |
| FY Dec 2023 | +10.8% |
| FY Dec 2022 | +4.7% |
| FY Dec 2021 | +5.1% |
| Jun 2026 | -20.4% |
| Mar 2026 | -26.1% |
| Dec 2025 | -28.8% |
| Sep 2025 | -21.9% |
| Jun 2025 | +7.5% |
| Mar 2025 | +12.6% |
| Dec 2024 | +12.7% |
| Sep 2024 | +11.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-6.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CNC
| FY Dec 2025 | -8.4% |
| FY Dec 2024 | +4.0% |
| FY Dec 2023 | +3.3% |
| FY Dec 2022 | +1.5% |
| FY Dec 2021 | +1.8% |
| Jun 2026 | -6.0% |
| Mar 2026 | -7.7% |
| Dec 2025 | -8.4% |
| Sep 2025 | -6.4% |
| Jun 2025 | +2.4% |
| Mar 2025 | +4.1% |
| Dec 2024 | +4.0% |
| Sep 2024 | +3.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital CNC
| FY Dec 2025 | n/a |
| FY Dec 2024 | +8.5% |
| FY Dec 2023 | +7.8% |
| FY Dec 2022 | +2.6% |
| FY Dec 2021 | +4.0% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | +4.9% |
| Mar 2025 | +9.3% |
| Dec 2024 | +8.5% |
| Sep 2024 | +7.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-12.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CNC
| FY Dec 2025 | -17.3% |
| FY Dec 2024 | +6.6% |
| FY Dec 2023 | +6.1% |
| FY Dec 2022 | +2.6% |
| FY Dec 2021 | +3.6% |
| Jun 2026 | -12.3% |
| Mar 2026 | -16.0% |
| Dec 2025 | -17.3% |
| Sep 2025 | -12.7% |
| Jun 2025 | +3.8% |
| Mar 2025 | +7.2% |
| Dec 2024 | +6.6% |
| Sep 2024 | +5.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing CNC
| FY Dec 2025 | n/a |
| FY Dec 2024 | 9.62x |
| FY Dec 2023 | 15.05x |
| FY Dec 2022 | 39.43x |
| FY Dec 2021 | 36.30x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 13.24x |
| Mar 2025 | 8.97x |
| Dec 2024 | 9.62x |
| Sep 2024 | 13.02x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$25.6B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CNC
| FY Dec 2025 | $19.7B |
| FY Dec 2024 | $35.1B |
| FY Dec 2023 | $40.3B |
| FY Dec 2022 | $52.4B |
| FY Dec 2021 | $53.8B |
| Jun 2026 | $23.7B |
| Mar 2026 | $11.2B |
| Dec 2025 | $19.7B |
| Sep 2025 | $18.0B |
| Jun 2025 | $30.1B |
| Mar 2025 | $33.6B |
| Dec 2024 | $35.1B |
| Sep 2024 | $42.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+26.6%
TTM free cash flow over market value at close 2026-10-26
FCF yield CNC
| FY Dec 2025 | +21.4% |
| FY Dec 2024 | -1.6% |
| FY Dec 2023 | +18.3% |
| FY Dec 2022 | +11.3% |
| FY Dec 2021 | +6.9% |
| Jun 2026 | +28.2% |
| Mar 2026 | +44.2% |
| Dec 2025 | +21.4% |
| Sep 2025 | +19.2% |
| Jun 2025 | +4.0% |
| Mar 2025 | +5.0% |
| Dec 2024 | -1.6% |
| Sep 2024 | +0.6% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing CNC
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.35x |
| FY Dec 2023 | 0.11x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 0.26x |
| Dec 2024 | 0.35x |
| Sep 2024 | 0.45x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $194.8B | $163.1B | $154.0B | $144.5B |
| Gross profit | $14.2B | $17.1B | $17.6B | $16.9B |
| Operating income | -$7.6B | $3.2B | $2.9B | $1.3B |
| Net income | -$6.7B | $3.3B | $2.7B | $1.2B |
| EPS (diluted) | -13.53 | 6.31 | 4.95 | 2.07 |
| Operating cash flow | $5.1B | $154.0M | $8.1B | $6.3B |
| Cash | $17.9B | $14.1B | $17.2B | $12.1B |
| Long-term debt | $17.4B | $18.4B | $17.7B | $17.9B |
| Buybacks | $475.0M | $3.1B | $1.6B | $3.1B |
SEC XBRL, fiscal years, as known on 2026-10-28
CNC Stock Sonar score 6/7 axes
Find similar shapesCompareCNC ranks highest on institutional and government (90th percentile) and growth (68th), and lowest on insider conviction (10th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CNC filings, in plain words
Are Centene insiders buying or selling CNC?
In the 180 days to 2026-10-28, Centene insiders were net sellers, a net $12.1M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded CNC?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Tim Moore dated 2025-08-18.
Are there planned insider sales of CNC?
Yes. 4 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $16.5M of stock; the latest, by Burdick Kenneth A, was filed 2026-08-26.
Read the full summary
In the 180 days to 2026-10-28, Centene insiders were net sellers of CNC, a net $12.1M across purchases and sales reported on Form 4 by 2 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in CNC, none in the last year; the latest on record is a sale by Tim Moore dated 2025-08-18. Insiders filed 4 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $16.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
